Ligand validation:3VQ2

MYR: MYRISTIC ACID

MYR is a Ligand Of Interest in 3VQ2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VQ2_MYR_D_303	13%	58%	0.334	0.887	0.88	0.72	1	-	0	0	94%	0.9375
3VQ2_MYR_C_303	10%	59%	0.375	0.897	0.88	0.68	1	-	0	0	94%	0.9375
5IJD_MYR_D_807	9%	63%	0.341	0.841	0.37	1.03	-	1	2	0	94%	0.9375
8Q2Z_MYR_C_201	93%	68%	0.081	0.975	0.46	0.77	-	-	0	0	100%	0.9375
6NOK_MYR_A_401	92%	52%	0.077	0.967	0.71	1.14	-	2	0	0	100%	1
8Q3D_MYR_D_101	92%	65%	0.086	0.975	0.53	0.81	-	-	0	0	100%	0.9375
4LB9_MYR_A_602	89%	60%	0.068	0.947	0.59	0.94	-	1	2	0	100%	1
7OWO_MYR_D_401	88%	73%	0.088	0.962	0.45	0.59	-	-	0	0	100%	0.525

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.